JESSICA ROTH: Open Payments
NPI 1407327224 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,856 in 113 payments from 18 companies in 2025. Trend: 2023 $3,426 · 2024 $4,272 · 2025 $2,856
Food & beverage: $2,721Education: $135
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $1,026 |
| Janssen Biotech, Inc. | 18 | $420 |
| Madrigal Pharmaceuticals | 9 | $280 |
| Ipsen Biopharmaceuticals, Inc | 6 | $261 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $253 |
| Regeneron Healthcare Solutions, Inc. | 5 | $101 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $94 |
| Aimmune Therapeutics, Inc. | 1 | $89 |
| Phathom Pharmaceuticals, Inc. | 5 | $77 |
| Enterra Medical, Inc. | 1 | $63 |
Products named: TREMFYA, RINVOQ, CREON, REZDIFFRA, IQIRVO, SKYRIZI, ENTYVIO, DUPIXENT.
Industry payments across TX — which companies pay providers there.
